4 ms·
One of the big questions I have is what happens if there's no significant financial incentive tied to a therapy. Lithium seems quite promising, for example. How
by fny 4y ago
One of the big questions I have is what happens if there's no significant financial incentive tied to a therapy. Lithium seems quite promising, for example. However, it's an abundant salt that requires very little research (meager funding opportunities) and can't be patented (non-existent commercialization opportunities.)
- AlotOfReading 4y agoYou can still IP protect delivery mechanisms and branding. Insulin and tums are examples, respectively. I don't see what the potential for issues here is unless it's an ultra-rare disease where the total market isn't worth the certification costs. That doesn't describe Alzheimer's.